Skip to main content
. 2023 Aug 14;12(8):1527–1539. doi: 10.21037/tp-23-42

Table 3. Summary of studies using the SNOO smart bassinet as a therapeutic agent (26).

Location of study Aim(s) Results
University of Amsterdam Babylab (37) To assess the use of the SNOO to manage colicky infants - “It was not clear whether the parent or the crib is more effective for soothing babies.
- Babies naturally need human contact for comfort. The crib could be an addition to all the good things that parents themselves are doing to soothe their baby
- “The crib might be a solution especially for parents with a crying infant. Sometimes they become so exhausted that they react less sensitively and responsively to their baby, which can result in a vicious circle in which the parent and the baby increasingly bring each other out of balance: more crying by the baby and even more exhaustion in the parent.
- “Smart cribs might also offer a solution in hospitals and relieve staff.
- “It is now important to do follow-up research into the soothing effects of swaddling, movement, and sound by the parent and a smart crib in the home environment.
- “Möller and Rodenburg are already doing small-scale research in which a smart crib is placed at parents’ home. The results are promising: babies and parents sleep meaningfully better and crying also decreases significantly. ‘Parents are often so satisfied with the crib, that they even ask if they can use it a bit longer.’
Bellarmine University and Baptist Health Hospital (28) To explore the effects of SNOO on improving breastfeeding initiation and safe sleep in a hospital environment - No published results available
Children’s Mercy Hospital (38) To evaluate the willingness of staff and parents of cardiac infants to utilize the SNOO during recovery from cardiac surgery. A secondary objective was to determine how timestamped “clinical data elements could be aligned with the SNOO sleep log to allow for future investigation of physiologic trends during SNOO usage”. - Demonstrated feasibility of using SNOO for certain postoperative cardiac infants was demonstrated with parental enrollment and staff use
- Established process to collect and overlay data from clinically obtained participant vital signs, medication administration and SNOO sleep log was demonstrated
- Future broader trials may include evaluation of the physiological response to SNOO, larger scale inpatient and expanded remote patient home monitoring use
Children’s Mercy Hospital (39) To investigate the effects of SNOO on improving the rate of healing in infants recovering from single ventricle repair - No published results available
University of California San Diego (28) To explore the effects of SNOO on mothers diagnosed with postpartum depression - No published results available
University of Colorado, Colorado Springs and Monash University, Melbourne (40) To study the effects of SNOO in preventing postpartum insomnia and anxiety in mothers - “Rates of depression were estimated to be 20–50% lower than expected. Compared to the 22% to 41% rates of depression reported among a lower-risk sample of new mothers during COVID, just 17.7% of high-risk mothers using SNOO screened positive for PPD.
- “The number of new mothers suffering from insomnia was less than half of the expected number. While 18.2% using SNOO met the clinical criteria for insomnia, this was lower than the expected incidence of approximately 46%.
- “Rates of anxiety were lower than expected. The average rate for high-risk mothers using SNOO was 31.8% as compared to 42.8% reported in a study of lower risk women during COVID.
- “SNOO is a responsive ‘smart’ bassinet. Its womb-like sound and motion calms fussing, improves sleep, and reduces night waking—all factors that raise the risk of PPD. SNOO also prevents accidental rolling to an unsafe position, a common cause of parental anxiety.
Boston Children’s, University of Kentucky, Hoops Children’s, Norton Children’s, WV University, Oakland Children’s, UCSD, etc. (28) To study the use of SNOO as a treatment for infants withdrawing from opiates - No published results available

PPD, postpartum depression; COVID, coronavirus disease.

HHS Vulnerability Disclosure